Works matching IS 11795573 AND DT 2011
Results: 3
Long-Term Safety and Tolerability of Open-Label Olanzapine Long-Acting Injection in the Treatment of Schizophrenia: 190-Week Interim Results.
- Published in:
- Clinical Medicine Insights: Psychiatry, 2011, n. 3, p. 37, doi. 10.4137/CMPsy.S6659
- By:
- Publication type:
- Article
Generalized Anxiety Disorder in Adults: Focus on Pregabalin.
- Published in:
- Clinical Medicine Insights: Psychiatry, 2011, n. 3, p. 17, doi. 10.4137/CMPsy.S5069
- By:
- Publication type:
- Article
A Retrospective (Post-Marketing) Case Series of Patients Receiving Intramuscular (IM) Olanzapine Outside of Product Doses and Indications (Off-Label): Assessing Safety and Tolerability.
- Published in:
- Clinical Medicine Insights: Psychiatry, 2011, n. 3, p. 1, doi. 10.4137/CMPsy.S6550
- By:
- Publication type:
- Article